Terms: = Prostate cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884 AND Diagnosis
6 results:
1. Advances in the role of heat shock protein 90 in prostate cancer.
Fu Z; Jia B
Andrologia; 2022 May; 54(4):e14376. PubMed ID: 35075667
[TBL] [Abstract] [Full Text] [Related]
2. Preclinical Evaluation of [
Vermeulen K; Cools R; Briard E; Auberson Y; Schoepfer J; Koole M; Cawthorne C; Bormans G
ACS Chem Neurosci; 2021 Oct; 12(20):3915-3927. PubMed ID: 34597516
[TBL] [Abstract] [Full Text] [Related]
3. Molecular Chaperones in Osteosarcoma: diagnosis and Therapeutic Issues.
Lallier M; Marchandet L; Moukengue B; Charrier C; Baud'huin M; Verrecchia F; Ory B; Lamoureux F
Cells; 2021 Mar; 10(4):. PubMed ID: 33808130
[TBL] [Abstract] [Full Text] [Related]
4. Fully Automated, Label-Free Isolation of Extracellular Vesicles from Whole Blood for cancer diagnosis and Monitoring.
Sunkara V; Kim CJ; Park J; Woo HK; Kim D; Ha HK; Kim MH; Son Y; Kim JR; Cho YK
Theranostics; 2019; 9(7):1851-1863. PubMed ID: 31037143
[TBL] [Abstract] [Full Text] [Related]
5. Clinical, Prognostic and Therapeutic Significance of Heat Shock Proteins in cancer.
Saini J; Sharma PK
Curr Drug Targets; 2018; 19(13):1478-1490. PubMed ID: 28831912
[TBL] [Abstract] [Full Text] [Related]
6. Radioactive iodine labeling of monoclonal antibody against hsp90α and its use in diagnostic imaging in prostate cancer xenograft model.
Sun HW; Wang RF; Yan P; Zhang CL; Hao P; Ma H; Chen XQ
Eur Rev Med Pharmacol Sci; 2015; 19(5):835-43. PubMed ID: 25807438
[TBL] [Abstract] [Full Text] [Related]
